Altamira Therapeutics Stock Statistic Functions Beta

CYTO Stock  USD 0.43  0.01  2.38%   
Altamira Therapeutics statistic functions tool provides the execution environment for running the Beta function and other technical functions against Altamira Therapeutics. Altamira Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of statistic functions indicators. As with most other technical indicators, the Beta function function is designed to identify and follow existing trends. Altamira Therapeutics statistical functions help analysts to determine different price movement patterns based on how price series statistical indicators change over time. Please specify Time Period to run this model.

Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Altamira Therapeutics correlated with the market. If Beta is less than 0 Altamira Therapeutics generally moves in the opposite direction as compared to the market. If Altamira Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Altamira Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Altamira Therapeutics is generally in the same direction as the market. If Beta > 1 Altamira Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.

Altamira Therapeutics Technical Analysis Modules

Most technical analysis of Altamira Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Altamira from various momentum indicators to cycle indicators. When you analyze Altamira charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Altamira Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Altamira Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Altamira Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Altamira Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Altamira Therapeutics's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Altamira Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Altamira Therapeutics, we also check how macroeconomic factors affect Altamira Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2010 2022 2023 2024 (projected)
Payables Turnover0.630.30.350.52
Days Of Inventory On Hand136.712.943.393.22
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Altamira Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.425.21
Details
Intrinsic
Valuation
LowRealHigh
0.020.415.20
Details
Naive
Forecast
LowNextHigh
0.010.465.25
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.66-0.66-0.66
Details

Align your values with your investing style

In addition to having Altamira Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Gambling Idea
Gambling
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Momentum Idea
Momentum
Invested over 60 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 40 shares
Blockchain Idea
Blockchain
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Business Services Idea
Business Services
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
When determining whether Altamira Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Altamira Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Altamira Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Altamira Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altamira Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Altamira Stock, please use our How to Invest in Altamira Therapeutics guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Altamira Therapeutics. If investors know Altamira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Altamira Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
1.82
Revenue Per Share
0.917
Quarterly Revenue Growth
(0.64)
Return On Assets
(0.57)
Return On Equity
(3.69)
The market value of Altamira Therapeutics is measured differently than its book value, which is the value of Altamira that is recorded on the company's balance sheet. Investors also form their own opinion of Altamira Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Altamira Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Altamira Therapeutics' market value can be influenced by many factors that don't directly affect Altamira Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Altamira Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Altamira Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Altamira Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.